The 6-min walking distance: Long term follow up in patients with COPD

European Respiratory Journal

Volumn 29, Issue 3, 2007, Pages 535-540

  Casanova, C ^a   Cote, C G ^d   Marin, J M ^b   de Torres, J P ^a   Aguirre Jaime, A ^a   Mendez, R ^c   Dordelly, L ^d   Cell, B R ^e  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^c Jose I Baldo Hospital   (Venezuela)

^d Bay Pines VA Medical Center   (United States)

^e ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

6 min walking distance; Chronic obstructive pulmonary disease

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE COURSE; DISEASE SEVERITY; EXERCISE TEST; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL CAPACITY; PRIORITY JOURNAL; REFERENCE VALUE; STAGING; WALKING;

ADULT; AIRWAY RESISTANCE; BRONCHODILATOR AGENTS; COHORT STUDIES; DISEASE PROGRESSION; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPIROMETRY; VITAL CAPACITY; WALKING;

EID: 33847713421     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00071506     Document Type: Article

References (30)

1. Celli BR, Cote C, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-1012.
2. Celli BR, MacNee W, ATS/ERS Task Force, Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932-946.
3. Miyamoto S, Nagaya N, Satoh T, et al. Clinical correlates and prognostic significance of 6 minute walk in patients with pulmonary hypertension. Comparison with cardio-pulmonary exercise testing. Am J Respir Crit Care Med 2000; 161: 487-492.
4. Eaton T, Young P, Milne D, Wells AU. Six-minute walk, maximal exercise test: reproducibility in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 2005; 171: 1150-1157.
5. Chetta A, Pisi G, Zanini A, et al. Six minute walking test in cystic fibrosis adults with mild to moderate lung disease: comparison to healthy subjects. Respir Med 2001; 95: 986-991.
6. Herridge MS, Cheung AM, Tansey CM, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003; 348: 683-693.
7. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories, ATS Statement: guidelines for the six-minute walk test, Am J Respir Crit Care Med 2002; 166: 111-117.
8. McGavin CR, Gupta SP, McHardy GRJ. Twelve minute walking test for assessing disability in chronic bronchitis. BMJ 1976; 1: 822-823.
9. Butland RJA, Pang J, Gross ER, Woodcock AA, Geddes DM. Two, six and 12-minute walking test in respiratory disease. BMJ 1982; 284: 1607-1608.
10. Enright PL, McBurnie NLN, Bittner V, et al. The 6-min walk test: a quick measure of functional status in elderly adults. Chest 2003; 123: 387-398.
11. Casanova C, Cote C, de Torres JP, et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171: 591-597.
12. Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004; 23: 28-33.
13. Cahalin L, Pappagianopoulos P, Prevost S, Wain J, Ginns L. The relationship of the 6-min walk test to maximal oxygen consumption in transplant candidates with end-stage lung disease. Chest 1995; 108: 452-459.
14. Carter R, Holiday DB, Nwasuruba C, Stocks J, Grothues C, Tiep B. 6-minute walk work for assessment of functional capacity in patients with COPD. Chest 2003; 123: 1408-1415.
15. Casas A, Vilaro J, Rabinovich R, et al. Encouraged 6-min walking test indicates maximum sustainable exercise in COPD patients. Chest 2005; 128: 55-61.
16. Solway S, Brooks D, Lacasse Y, Thomas S. A quantitative systematic overview of the measurement properties of functional walk test used in the cardiorespiratory domain. Chest 2001; 119: 256-270.
17. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171: 972-977.
18. Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 1998; 158: 1384-1387.
19. Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J 1999; 14: 270-274.
20. Lung function testing, selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis 1991; 144: 1202-1218.
21. Sciurba FC, Slivka WA. Six-minute walk-testing. Semin Respir Crit Care Med 1998; 9: 383-391.
22. Charlson M, Szatrowsky T, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47: 1245-1251.
23. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 785-790.
24. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276.
25. Fletcher CM, Peto R, Tinker C, Speizer FE. The Natural History of Chronic Obstructive Lung Disease in Working Men in London. New York, Oxford University Press, 1976.
26. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M. Exercise capacity deterioration in patients with COPD: longitudinal evaluation over 5 years. Chest 2005; 128: 62-69.
27. Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH. Interpreting small differences in functional status: the six minute walk test in chronic lung disease patients. Am J Respir Crit Care Med 1997; 155: 1278-1282.
28. Olsson LG, Swedberg K, Clark AL, Witte KK, Cleland JG. Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. Eur Heart J 2005; 26: 778-793.
29. Agusti AG, Sauleda J, Miralles C, et al. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166: 485-489.
30. Montes de Oca M, Torres SH, De Sanctis J, Mata A, Hernández N, Tálamo C. Skeletal muscle inflammation and nitric oxide in patients with COPD. Eur Respir J 2005; 26: 390-397.